Technical Analysis for BIO - Bio-Rad Laboratories, Inc.
|Grade||Last Price||% Change||$ Change|
BIO closed down 0.63 percent on Tuesday, February 21, 2017, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: Feb 23
Trend Table & Recent Alerts
|Weak or Absent||Up||Up||Up|
|See historical BIO trend table...|
|Date||Alert Name||Type||% Chg|
|Feb 21||New 52 Week High||Bullish||0.00%|
|Feb 21||Stochastic Sell Signal||Bearish||0.00%|
|Feb 15||Stochastic Reached Overbought||Other||-0.08%|
|Feb 8||Hammer Candlestick||Bullish||1.46%|
|Feb 3||Bollinger Band Squeeze||Range Contraction||0.50%|
|Feb 2||NR7||Range Contraction||1.45%|
|Feb 2||Narrow Range Bar||Range Contraction||1.45%|
|Feb 2||Bollinger Band Squeeze||Range Contraction||1.45%|
|Feb 1||Bollinger Band Squeeze||Range Contraction||1.28%|
|Jan 31||Bollinger Band Squeeze||Range Contraction||1.04%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
- Earnings date: 2017-02-23
- Sector: Capital Goods
- Industry: Biotechnology: Laboratory Analytical Instruments
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, and to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Is BIO a Buy, Sell or Hold?
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more BIO news...
|52 Week High||194.25|
|52 Week Low||130.12|
|200-Day Moving Average||162.45|
|50-Day Moving Average||186.24|
|20-Day Moving Average||189.77|
|10-Day Moving Average||191.05|
|Average True Range||2.86|
|Chandelier Exit (Long, 3 ATRs)||185.67|
|Chandelier Exit (Short, 3 ATRs)||192.01|
|Upper Bollinger Band||194.03|
|Lower Bollinger Band||185.51|
|Percent B (%b)||0.77|